Two-dimensional in vivo rectal dosimetry using an endorectal balloon with unfoldable radiochromic film during prostate cancer radiotherapy. Issue 2 (August 2016)

• Record Type: Journal Article
• Authors: Jeang, Eun Hee; Min, Soonki; Cho, Kwan Ho; Hwang, Ui-Jung; Choi, Sang Hyoun; Kwak, Jungwon; Jeong, Jong Hwi; Kim, Haksoo; Lee, Se Byeong; Shin, Dongho; Park, Jeonghoon; Kim, Joo-Young; Kim, Dae Yong; Lim, Young Kyung
• Is Part Of: Radiotherapy and oncology. Volume 120:Issue 2(2016:Aug.)
• Page Start: 327
• Page End: 332
• Publication Date: 2016-08
• Subjects: Prostate cancer -- Radiotherapy -- Endorectal balloon -- In vivo rectal dosimetry -- Radiochromic film; Oncology -- Periodicals; Radiotherapy -- Periodicals; Tumors -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- radiotherapy -- Periodicals; Radiotherapy -- Periodicals; Radiothérapie -- Périodiques; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9940642
• DOI: 10.1016/j.radonc.2016.05.003
• Languages: English
• ISSNs: 0167-8140

Abstract

Abstract: Background and purpose: The present study aims to investigate the feasibility of two-dimensional (2D) in vivo rectal dosimetry using an endorectal balloon for the radiotherapy of prostate cancer. Materials and methods: The endorectal balloon was equipped with an unfoldable radiochromic film. The film was unrolled as the balloon was inflated, and rolled as it was deflated. Its mechanical and imaging properties were tested, and the dosimetric effectiveness was evaluated in clinical photon and proton beams. Results: The size of the endorectal balloon including the film was linearly proportional to the volume of water filled in the balloon, and its position could be identified by X-ray radiography. The loss of dose information due to film cutting was within ±1 mm from the cutting line. Applying linear interpolation on cut film, the gamma passing rate was more than 95% for 2%/2 mm criteria. The measured dose profiles agreed with the plan within 3% and 4% for the photon and proton beams, respectively. A dose–volume histogram of the anterior rectal wall could be obtained from the measured dose distribution in the balloon, which also agreed well with the plan. Conclusions: 2D in vivo rectal dosimetry is feasible using the endorectal balloon with a radiochromic film in the radiotherapy of prostate cancer.